These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3879938

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C, Amsterdam D, Beam T, Gorzynski E.
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC, Jones RN, Barry AL, Thornsberry C.
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN, Nonikov VE, Gugutsidze EN, Sutormina TM, Makarova OV.
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [Abstract] [Full Text] [Related]

  • 52. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR, Stokes DH, Slocombe B, Sutherland R.
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Timentin and beta-lactamases.
    Labia R, Morand A, Péduzzi J.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():17-26. PubMed ID: 3487538
    [Abstract] [Full Text] [Related]

  • 56. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
    Corbel MJ, Ibrahim ME, Gill KP.
    Vet Rec; 1984 Nov 03; 115(18):465. PubMed ID: 6568786
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid.
    Wong CS, Palmer GS, Cynamon MH.
    J Antimicrob Chemother; 1988 Dec 03; 22(6):863-6. PubMed ID: 3149633
    [Abstract] [Full Text] [Related]

  • 59. Susceptibility testing with clavulanic acid: fixed concentration versus fixed ratio.
    Thomson CJ, Miles RS, Amyes SG.
    Antimicrob Agents Chemother; 1995 Nov 03; 39(11):2591-2. PubMed ID: 8585755
    [No Abstract] [Full Text] [Related]

  • 60. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R, Duval J.
    Pathol Biol (Paris); 1995 Apr 03; 43(4):245-52. PubMed ID: 7567109
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.